Catalogue of collaboration profilesback to list
Campus Geb. A1-1
PomBioTech is an award winning Biotech CRO located in Saarbrücken Germany. We have specialized on the biotechnological large scale production of drug metabolites (cytochom P450 metabolites and glucuronides) using recombinant yeasts of the species Schizosaccharomyces pombe.
Our scientists have succeeded in functionally expressing a range of important human drug metabolizing enzymes e.g. cytochromes P450, UDP-glucuronosyltransferases (UGT) and hydroxysteroid dehydrogenases (HSD). Using these genetically modified fission yeast strains we are able to offer our clients custom production of drug metabolites (cytochrom P450 metabolites and glucuronides) up to technical scale. Moreover, we also offer the generation of custom made fission yeast stains to meet your demands. Our clients from the pharmaceutical industry benefit from our services since they don’t need to perform time consuming chemical synthesis as well as the subsequent purification of the metabolite of interest.
back to list
Biotechnological production of drug metabolites
What we offer:
PomBioTech offers the custom production of drug metabolites using a biotechnological approach. This service is of special interest for ADME-Tox and Pharmacokinetics departments of pharmaceutical companies that are engaged in drug development processes. PomBioTech possesses a comprehensive set of different human cytochromes P450, UDP-glucuronosyltransferases (UGT) and hydroxysteroid dehydrogenases (HSD) expressing fission yeast strains to meet the demands of our customers. Using these strains we are able to offer custom production of drug metabolites up to technical scale as well as inhibitor screening systems.
Besides this we offer the generation of custom fission yeast strains.
What are we looking for:
PomBioTech is looking for partners/clients that can profit from our patented technology. Ideal partners are pharmaceutical companies or academic institutions that are focused on the examination of drug metabolites or pharmacokinetics of APIs.
Our goal is to either investigate whether a certain compound of interested can be metabolized to a desired product using our technology or if a protein of interest can be functionally expressed in fission yeast.
- Research & Development
- Joint Venture Agreement
- Commercial Agreement
Head of Business Development